PTC Therapeutics, Inc.
USD82.87
+1.30 (+1.59%)
CEO
Matthew Klein
IPO Date
2013-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$81.71
Prev. Close
$81.57
Day Low
$80.68
Day High
$83.22
52W Low
$43.17
52W High
$87.50
Market Cap
$6.87B
Volume
0.81M
| 100 |
| $87.00 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Disposed | 401 | $38.10 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Disposed | 4,922 | $38.10 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Disposed | 1,001 | $38.10 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Disposed | 19,859 | $38.10 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Disposed | 100 | $39.42 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Acquired | 401 | $38.10 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | S-Sale | Disposed | 401 | $85.01 |
| 26 Jun 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Acquired | 4,922 | $38.10 |